INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Apr 13, 2007 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 1,200 | -- | 5,461 |
Apr 13, 2007 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 500 | -- | 4,961 |
Apr 13, 2007 |
SVP, Manufuring Operations
Trans History: 109
|
SVP, Manufuring Operations | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 153 | -- | 4,808 |
Apr 13, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 90,444 | -- | -- |
Apr 13, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 90,444 | $10.56 | 157,540 |
Apr 13, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 38,835 | $24.60 | 118,705 |
Apr 13, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 20,326 | $24.60 | 98,379 |
Apr 09, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,100 | $10.56 | 70,196 |
Apr 09, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Open market or private sale of non-derivative or derivative security | 3,100 | $23.80 | 67,096 |
Apr 09, 2007 |
Director, EVP, CSO, & Pres Regn Res Labs
Trans History: 673
|
Director, EVP, CSO, & Pres Regn Res Labs | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 715 | $10.56 | 67,811 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.